Cannabis Bioscience International Holdings, Inc. (CBIH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD.

Revenue TTM

0 150K 300K 450K Q4 '24: 248.8K Q1 '25: 354.9K Q2 '25: 365.4K Q3 '25: 343.9K Q4 '25: 303K Q1 '26: 148.3K Q2 '26: 127.4K Q3 '26: 123.6K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Gross Profit TTM

0 150K 300K 450K Q4 '24: 203.2K Q1 '25: 309.8K Q2 '25: 327.6K Q3 '25: 298.5K Q4 '25: 262.9K Q1 '26: 108.4K Q2 '26: 84.8K Q3 '26: 97.4K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Income TTM

-600K -400K -200K 0 200K 400K 600K Q4 '24: -460.9K Q1 '25: -381.7K Q2 '25: -346.8K Q3 '25: -316.1K Q4 '25: -421.4K Q1 '26: -398.5K Q2 '26: -434.8K Q3 '26: -398.8K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Net Income TTM

-750K -500K -250K 0 250K 500K 750K Q4 '24: -651.3K Q1 '25: -545.9K Q2 '25: -501K Q3 '25: -473K Q4 '25: -548.8K Q1 '26: -555.2K Q2 '26: -592.6K Q3 '26: -515.3K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Cost of Revenue TTM

0 20K 40K 60K Q4 '24: 45.6K Q1 '25: 45.1K Q2 '25: 37.9K Q3 '25: 45.4K Q4 '25: 40.1K Q1 '26: 39.9K Q2 '26: 42.6K Q3 '26: 26.2K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Cash Flow TTM

-600K -400K -200K 0 200K 400K 600K Q4 '24: -479.4K Q1 '25: -435.2K Q2 '25: -286K Q3 '25: -359.8K Q4 '25: -329.6K Q1 '26: -402.9K Q2 '26: -336.3K Q3 '26: -268.1K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 4B 8B 12B Q2 '24: 10.3B Q3 '24: 10.4B Q1 '25: 10.5B Q2 '25: 10.5B Q3 '25: 10.7B Q1 '26: 11.6B Q2 '26: 11.6B Q3 '26: 11.6B Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 Q4 '24: -0.00 Q1 '25: -0.00 Q2 '25: -0.00 Q3 '25: -0.00 Q4 '25: -0.00 Q1 '26: -0.00 Q2 '26: -0.00 Q3 '26: -0.00 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.